Product Comparison

Comparison Options

• Print
• Email

McKesson #	1095763	811706	1233170	885048	721146
Description	Medroxyprogesterone Acetate 150 mg / mL Injection 1 mL	Depo-Provera® CI Medroxyprogesterone Acetate 150 mg / mL Injection 1 mL	Medroxyprogesterone Acetate 150 mg / mL Injection 1 mL	Xulane™ Norelgestromin / Ethinyl Estradiol 150 mcg - 35 mcg / 24 Hour Patch 3 Patches	depo-subQ provera 104™ Medroxyprogesterone Acetate 104 mg / 0.65 mL Injection 0.65 mL
Manufacturer #	00548570100	00009737611	55150033001	00378334053	00009470913
Brand		Depo-Provera® CI		Xulane™	depo-subQ provera 104™
Manufacturer	Amphastar Pharma	Pfizer Pharmaceuticals (Brand)	Auromedics Pharmaceuticals	Mylan Pharmaceuticals	Pfizer Pharmaceuticals (Brand)
Invoice	MEDROXYPROGESTERONE, PFS 150MG/ML 1ML	DEPO-PROVERA SAF, SYR 150MG/ML1ML	MEDROXYPROGESTERONE ACETATE, PFS 150MG/ML 1ML	XULANE NORELGES, PATCH 150-35MG/24HR (3/CT)	DEPO-SUBQ PROVERA, SYR 104MG/0.65ML 0.65ML
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	3751005		2662757	2054724
Container Type	Prefilled Syringe	Prefilled Syringe	Prefilled Syringe	Pouch	Prefilled Syringe
Country of Origin	United States	Unknown	India	Unknown	Unknown
Dosage Form	Injection	Injection	Injection	Patch	Injection
Generic Drug Code	11254	11254	11254	15524	24471
Generic Drug Name	Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	Norelgestromin / Ethinyl Estradiol	Medroxyprogesterone Acetate
NDC Number	00548570100	00009737611	55150033001	00378334053	00009470913
Quantity				3 Patches
Strength	150 mg / mL	150 mg / mL	150 mg / mL	150 mcg - 35 mcg / 24 Hour	104 mg / 0.65 mL
Type	Intramuscular	Intramuscular	Intramuscular	Transdermal	Subcutaneous
UNSPSC Code	51351612	51351612	51351509	51352414	51351612
Volume	1 mL	1 mL	1 mL		0.65 mL
Application	Contraceptive Agent	Contraceptive Agent	Contraceptive Agent	Contraceptive Agent	Contraceptive Agent
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits	Generic Equivalent to Depo-Provera® WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov	Depo-Provera CI is a progestin indicated only for the prevention of pregnancy The recommended dose is 150 mg of Depo-Provera CI every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle Prefilled syringes packaged with 22-gauge x 1-1/2 inch Terumo® SurGuard™ needles Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP]			depo-subQ provera 104 must be given by subcutaneous injection into the anterior thigh or abdomen, once every 3 months (12 to 14 weeks) depo-subQ provera 104 is not formulated for intramuscular injection The pre-filled syringe of depo-subQ provera 104 must be vigorously shaken just before use to create a uniform suspension Supplied as a pre-filled syringe, packaged with a 26-gauge x 3/8 inch Terumo® Surguard™ needle Store at controlled room temperature 20º to 25º C (68º to 77ºF)